Evidence map›Paper›PMID 42577805›Full record

ArticleJBMR plus2026

Response to Letter to the Editor on "Romosozumab for the treatment of thalassemia-associated osteoporosis in two female patients".

Maria P Yavropoulou, Maria-Evangelia Koloutsou, Polyxeni Delaporta, Polyzois Makras, Athanasios D Anastasilakis, Eva Kassi, Antonis Kattamis, Paraskevi Xekouki

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in JBMR plus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maria P YavropoulouEndocrinology Unit, First Department of Propaedeutic and Internal Medicine, Medical School, National and Kapodistrian University of Athens, LAIKO University Hospital, C.E.R.E.D, ENDO-ERN Center, Athens 11527, Greece.
Maria-Evangelia KoloutsouEndocrinology Unit, First Department of Propaedeutic and Internal Medicine, Medical School, National and Kapodistrian University of Athens, LAIKO University Hospital, C.E.R.E.D, ENDO-ERN Center, Athens 11527, Greece.ORCID https://orcid.org/0000-0002-6898-1357
Polyxeni DelaportaThalassemia Unit, First Department of Pediatrics, National and Kapodistrian University of Athens, `Aghia Sophia' Children's Hospital, ERN-EuroBloodNet Center, Athens 11527, Greece.
Polyzois MakrasDepartment of Endocrinology and Diabetes and Department of Medical Research, 251 Hellenic Air Force & VA General Hospital, Athens 11525, Greece.ORCID https://orcid.org/0000-0002-3231-3357
Athanasios D AnastasilakisDepartment of Endocrinology, 424 Military General Hospital, Thessaloniki 56429, Greece.ORCID https://orcid.org/0000-0002-9624-6296
Eva KassiEndocrinology Unit, First Department of Propaedeutic and Internal Medicine, Medical School, National and Kapodistrian University of Athens, LAIKO University Hospital, C.E.R.E.D, ENDO-ERN Center, Athens 11527, Greece.
Antonis KattamisThalassemia Unit, First Department of Pediatrics, National and Kapodistrian University of Athens, `Aghia Sophia' Children's Hospital, ERN-EuroBloodNet Center, Athens 11527, Greece.
Paraskevi XekoukiEndocrinology and Diabetes Clinic, University Hospital of Heraklion, School of Medicine, University of Crete, 71500 Crete, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adverse effectsanabolic therapycardiovascular riskdrug safetyfracturesosteoporosisromosozumabsclerostin inhibitionthalassemia

Identifiers

PMID42577805
PMCPMC13455606

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.